Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GE HealthCare TechnologiesMEX:GEHC 67 Debt-to-Equity is 0.96 as of Jun. 2026, which is 12% below its 10-year median of 1.09. GuruFocus rates MEX:GEHC with a GF Score™ of 67/100 and a GF Value™ of MXN1,386.17 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 706 Medical Devices & Instruments companies, GE HealthCare Technologies ranks worse than 83.29% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for GE HealthCare Technologies's Debt-to-Equity or its related term are showing as below:
MEX:GEHC'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 1.09 Max: 1.53
Current: 0.96
During the past 7 years, the highest Debt-to-Equity Ratio of GE HealthCare Technologies was 1.53. The lowest was 0.00. And the median was 1.09.
MEX:GEHC's Debt-to-Equity is ranked worse than 83.29% of 706
companies
in the Medical Devices & Instruments industry
Industry Median: 0.23
vs MEX:GEHC: 0.96
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
GE HealthCare Technologies Debt-to-Equity Related Terms
GE HealthCare Technologies Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:GEHC vs DXCM, STE, ZBH: Debt-to-Equity Comparison
For the Medical Devices subindustry, GE HealthCare Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GE HealthCare Technologies Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GE HealthCare Technologies's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where GE HealthCare Technologies's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GE HealthCare Technologies (MEX:GEHC) has a Debt-to-Equity of 0.96 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on GE HealthCare Technologies and its competitors. This is 12% below median its historical median of 1.09. According to the industry distribution chart, GE HealthCare Technologies ranks #588 out of 706 companies in the Medical Devices & Instruments industry, placing it in the top 83.3%.
Is GE HealthCare Technologies' Debt-to-Equity too high?
GE HealthCare Technologies' current Debt-to-Equity of 0.96 is 12% below median its 10-year median of 1.09. The Medical Devices & Instruments industry median Debt-to-Equity is 0.23. GE HealthCare Technologies' value of 0.96 is 317.4% above this industry median. Based on the distribution chart, GE HealthCare Technologies ranks #588 out of 706 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, GE HealthCare Technologies has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' Debt-to-Equity compare to DXCM and STE?
According to the Medical Devices & Instruments industry distribution chart, GE HealthCare Technologies ranks #588 out of 706 companies for Debt-to-Equity. This places GE HealthCare Technologies in the lower half of its industry. The industry median Debt-to-Equity is 0.23. GE HealthCare Technologies' value of 0.96 is 317.4% above this benchmark. While the company's 10-year median is 1.09 vs. the industry median of 0.23, GE HealthCare Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 706 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GE HealthCare Technologies's current Debt-to-Equity of 0.96 is 317.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on GE HealthCare Technologies and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GE HealthCare Technologies's current Debt-to-Equity is 0.96, which is 12% below median its own 10-year median of 1.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (MEX:GEHC) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,386.17, compared to a current price of MXN1,150.00 — trading 17% below its estimated fair value. The current Debt-to-Equity is 0.96, which is 12% below median its 10-year median of 1.09 and 317.4% above the Medical Devices & Instruments industry median of 0.23. GE HealthCare Technologies' overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For GE HealthCare Technologies (MEX:GEHC), the current Debt-to-Equity is 0.96 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GE HealthCare Technologies (MEX:GEHC) Overvalued in 2026?
Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued.
The current stock price of MXN1,150.00 is trading 17% below its estimated GF Value™ of MXN1,386.17.
GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.
Key valuation signals for MEX:GEHC:
Debt-to-Equity: 0.96 (12% below median its 10-year median of 1.09)
GF Value™: MXN1,386.17 vs. price of MXN1,150.00 (17% below fair value)
Industry Position: 317.4% above the Medical Devices & Instruments median (#588 of 706)
No single metric tells the full story. See the MEX:GEHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
67GF Score
Get the complete analysis for MEX:GEHC
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GEHC has been successfully added to your 
